GIM
Greylin Investment Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-38,155
| Closed | -$1.66M | – | 72 |
|
|
2022
Q2 | $1.66M | Buy |
38,155
+17,665
| +86% | +$769K | 0.32% | 36 |
|
|
2022
Q1 | $893K | Buy |
20,490
+7,065
| +53% | +$308K | 0.15% | 43 |
|
|
2021
Q4 | $592K | Buy |
+13,425
| New | +$592K | 0.11% | 58 |
|
|
2018
Q4 | – | Sell |
-5,125
| Closed | -$206K | – | 79 |
|
|
2018
Q3 | $206K | Sell |
5,125
-14,630
| -74% | -$588K | 0.04% | 74 |
|
|
2018
Q2 | $796K | Sell |
19,755
-10,075
| -34% | -$406K | 0.17% | 48 |
|
|
2018
Q1 | $1.17M | Sell |
29,830
-38,195
| -56% | -$1.49M | 0.25% | 43 |
|
|
2017
Q4 | $2.41M | Sell |
68,025
-43,385
| -39% | -$1.54M | 0.52% | 29 |
|
|
2017
Q3 | $4.52M | Sell |
111,410
-2,155
| -2% | -$87.5K | 1.04% | 19 |
|
|
2017
Q2 | $4.9M | Sell |
113,565
-1,130
| -1% | -$48.7K | 1.13% | 18 |
|
|
2017
Q1 | $4.84M | Buy |
114,695
+10,305
| +10% | +$435K | 1.12% | 17 |
|
|
2016
Q4 | $4.02M | Buy |
104,390
+49,030
| +89% | +$1.89M | 0.96% | 16 |
|
|
2016
Q3 | $2.39M | Buy |
55,360
+550
| +1% | +$23.7K | 0.6% | 23 |
|
|
2016
Q2 | $2.38M | Buy |
54,810
+1,675
| +3% | +$72.6K | 0.59% | 23 |
|
|
2016
Q1 | $2.16M | Buy |
53,135
+990
| +2% | +$40.2K | 0.56% | 24 |
|
|
2015
Q4 | $2.1M | Buy |
+52,145
| New | +$2.1M | 0.56% | 24 |
|
|
2015
Q2 | – | Sell |
-22,205
| Closed | -$949K | – | 60 |
|
|
2015
Q1 | $949K | Buy |
+22,205
| New | +$949K | 0.23% | 34 |
|